>ヨーロッパの肺がんスクリーニングソフトウェア市場、配信モード別（クラウドベースのソリューション、オンプレミスソリューション、Webベースのソリューション）、製品別（肺がんスクリーニング放射線ソリューション、肺がんスクリーニング患者管理ソフトウェア、結節管理ソフトウェア、データ収集とレポート、患者調整とワークフロー、肺結節のコンピューター支援検出、病理学とがんのステージング、統計監査レポート、スクリーニングPAC、診療管理と監査ログ追跡）、タイプ別（コンピューター支援スクリーニングと従来のスクリーニング）、アプリケーション別（非小細胞肺がん（NSCLC）と小細胞肺がん（SCLC）、プラットフォーム別（スタンドアロンと統合）、購入モード別（機関と個人）、エンドユーザー別（腫瘍学センター、病院、外来手術センターなど）、流通チャネル別（直接入札とサードパーティ販売業者） - 2029年までの業界動向と予測。
ヨーロッパの肺がんスクリーニングソフトウェア市場の分析と規模
肺がんによる死亡率の抑制は、医療施設にとって大きな懸念事項の 1 つです。公的機関や民間組織は、死亡率を抑制するためのスクリーニング プログラムを開始する取り組みを行っています。さらに、企業は、患者のデータの管理を容易にし、厳格なデータ プライバシー ガイドラインに従ってより良いケアを提供するための高度なソフトウェアを導入しています。
肺がんの罹患率の増加、肺がんに対する人々の意識の高まり、政府の取り組みの増加、スクリーニング プログラムの増加は、市場の成長を牽引する主な要因の一部です。さらに、人工知能 (AI) ベースのソリューションの進歩と主要な市場プレーヤーによる戦略的取り組みにより、肺がんスクリーニング ソフトウェアの分野で機会が生まれています。
しかし、データプライバシーの問題と非熟練労働者の不足が、予測期間中の市場の成長を妨げると予想されます。
Data Bridge Market Research の分析によると、ヨーロッパの肺がんスクリーニング ソフトウェア市場は、予測期間中に 19.6% の CAGR で成長し、2029 年までに 27,518.34 千米ドルに達すると予想されています。クラウド ベースのソリューションは、市場における最大の配信モード セグメントを占めています。市場レポートでは、価格分析、特許分析、技術進歩についても詳細に取り上げています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2022年から2029年 |
|
基準年 |
2021 |
|
歴史的な年 |
2020 (2019～2014 にカスタマイズ可能) |
|
定量単位 |
収益は1000米ドル、価格は米ドル |
|
対象セグメント |
提供モード（クラウドベースのソリューション、オンプレミスソリューション、Web ベースのソリューション）、製品（肺がんスクリーニング放射線ソリューション、肺がんスクリーニング患者管理ソフトウェア、結節管理ソフトウェア、データ収集とレポート、患者調整とワークフロー、肺結節のコンピューター支援検出、病理学とがんのステージング、統計監査レポート、スクリーニング PAC、診療管理と監査ログ追跡）、タイプ（コンピューター支援スクリーニングと従来のスクリーニング）、アプリケーション（非小細胞肺がん（NSCLC）と小細胞肺がん（SCLC）、プラットフォーム（スタンドアロンと統合）、購入モード（機関と個人）、エンドユーザー（腫瘍学センター、病院、外来手術センターなど）、流通チャネル（直接入札とサードパーティの販売業者） |
|
対象国 |
ドイツ、イギリス、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他のヨーロッパ諸国 |
|
対象となる市場プレーヤー |
PenRad Technologies Inc.、Koninklijke Philips NV、Volpara Health Limited、Thynk Health、Nuance Communications, Inc.、Siemens Healthcare GmbH、MyCareWare, Inc.、MagView、MeVis Medical Solutions AG、Canon Medical Informatics, Inc.、General Electric Company、Epic Systems Corporation、Lungview、Eon、Medtronic、Coreline Soft Co., Ltd.、Optellum Ltd、HealthMyne、Oncocyte Corporation、Genesystem、REVEALDX、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche Ltd、Median Technologies、AstraZeneca、Aidence.com |
市場の定義
肺がんスクリーニングは、さまざまな技術とソフトウェアを使用して肺がんの段階を特定します。CT を使用した肺がんスクリーニングは、肺がんのスクリーニングに最も推奨される技術です。この技術の使用が増えると、肺がんスクリーニング用の高度なソフトウェアの必要性が加速すると予想されます。このソフトウェアは、肺スクリーニング プログラムへの患者の参加を管理するのに役立ち、医療専門家がデータを収集、整理し、臨床医と患者に転送するための効率的な方法を提供します。さらに、このソフトウェアは、リスクのある患者を特定し、統合された電子健康記録を使用してデータの流れを自動化します。
ヨーロッパの肺がんスクリーニングソフトウェア市場の動向
このセクションでは、市場の推進要因、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 世界的に肺がんの罹患率が増加
肺がんは、男性と女性の両方で死亡の主な原因です。世界がん研究基金インターナショナルによると、肺がんは世界で2番目に多いがんです。男性では最も一般的ながんで、女性では2番目に多いがんです。2020年には、2,200件を超える肺がんの新規症例がありました。肺がん症例の増加により、早期診断のための肺がんスクリーニングソフトウェアの導入の必要性が生まれ、市場成長の原動力となっています。
- 早期診断と頻繁な検査の利点に関する認識の向上
公的機関、非営利組織、民間組織による肺がんの啓発プログラムの高まりが、市場の成長を後押しすると予想されています。これらの取り組みは、病気を予防し、偏見や汚名を減らし、研究を促進することを目的としています。肺がんに関する国民の意識は高まっています。さまざまな組織による啓発プログラムが多数あるため、早期に診断されれば治癒できる肺がんについて人々は知っています。このように、国民の意識向上が市場の成長を牽引しています。
- さまざまな病気の検査プログラムを実施するための政府の取り組みが行われた。
がんの負担は世界的に増加し続けており、医療制度、製品、家族、個人に大きな経済的、感情的、身体的ストレスを与えています。医療制度が充実した国では、生存率、質の高いケア、意識の向上、早期発見の容易さにより、多くの種類のがんの生存率が向上しています。米国疾病予防管理センター、部族、米国太平洋諸島および領土は、国家包括的がん対策プログラム (NCCCP) を通じて、地域社会でがんと闘うための同盟を結成または支援することになっています。これらの取り組みにより、より多くの聴衆が教育を受け、より意識的に分散し、世界中の聴衆がさらなる予防策を講じ、予防検査を実践するよう促され、市場が促進されます。
- 世界中でスクリーニングプログラムが増加
スクリーニングは、がんの早期発見に効果的な方法です。発展途上国では肺がんの発生率が増加傾向にあります。乳がんや子宮頸がんのスクリーニングは定期的に推奨されていますが、肺がんの場合はそうではありません。ほとんどの国や機関が、肺がんに対する低線量コンピューター断層撮影(LDCT) の実現可能性と疾患スクリーニングを開始しています。肺がんのスクリーニング数の増加は、市場プレーヤーにチャンスをもたらしました。したがって、診断率の増加は市場成長の原動力として機能します。
機会
-
市場参加者間のコラボレーション、合併、買収の増加
市場で事業を展開している企業は、合併や買収、製品の発売、契約、パイプラインの開発、コラボレーション、市場拡大など、さまざまな戦略を採用して、さまざまな側面でビジネスを拡大しています。企業によるこれらの戦略的決定は、市場で事業を展開している市場プレーヤーに大きな機会を提供することが期待されています。
抑制/挑戦
- ソフトウェアの可用性に関する問題
発展途上国における肺がんスクリーニングの有効性と効率性、および肺がんスクリーニングソフトウェアの可用性に関連する特定の問題/障壁があります。問題とは、時間に対する競合する要求、肺がんスクリーニングに関する知識、スクリーニングの有効性に関する変化する態度、歴史的に貧弱な肺がん治療結果に関連する虚無主義、地方自治体または国の医療機器規制機関に対するトレーニングと要件の承認の制限です。これらすべての問題により、製品の発売と可用性が遅れます。また、肺がんスクリーニングソフトウェアの需要は、利用可能なソフトウェアに関連する技術的な問題によって妨げられ、市場の成長の抑制要因となっています。
COVID-19後の欧州肺がんスクリーニングソフトウェア市場への影響
COVID-19は、ほぼすべての国が必需品を扱う施設を除くすべての施設の閉鎖を選択したため、さまざまな業界に大きな影響を与えました。政府は、COVID-19の拡散を防ぐために、施設の閉鎖や非必需品の販売、国際貿易の遮断など、いくつかの厳しい措置を講じました。このパンデミックの状況下で運営されていた唯一のビジネスは、開業とプロセスの運営が許可された必須サービスでした。
COVID-19 は、医療提供者が患者ケアを提供する上で、新たな未知の課題を生み出しました。肺がんスクリーニングなど、必須ではないが重要なサービスの多くは、スタッフと患者の健康を守るために一時的に中断されました。医療機関は、COVID-19 中のケアの継続性を確保し、サービスを安全に継続できるようにするために、スケジュール設定、患者のモニタリング、患者とサービスのコミュニケーションのフォローアップに関して前例のない課題に直面しました。COVID-19 は肺がんスクリーニング プログラムに新たな課題を生み出し、多くの場合、スクリーニングが数か月遅れ、管理およびスケジュール設定チームにとってさらに困難が生じました。COVID-19 危機は呼吸補助の重要性に新たな光を当てましたが、がんスクリーニングの偏見を減らすことに大きな影響を与えることを期待しています。米国には肺がんスクリーニングの対象となる適格患者が 10,000,000 人以上いますが、スクリーニング プログラムに積極的に登録しているのはそのうちの 5% 未満です。COVID-19 は市場に悪影響を及ぼしました。
しかし、肺がんスクリーニングソフトウェア企業は苦戦しており、状況をコントロールするためにさまざまな戦略的決定を継続的に行っています。プレーヤーは、市場に関連する技術を向上させるために、パートナーシップ、コラボレーション、合併や買収などの戦略的活動に関与しています。これにより、企業は市場に高度で正確なソリューションをもたらします。さらに、業界全体のデジタル化を促進する政府の取り組みも市場の成長につながっています。
最近の動向
- GEヘルスケアは2022年7月、最新製品であり最先端の超音波装置である次世代のVoluson Expert 22を発売しました。GEヘルスケアの受賞歴のある女性の健康ポートフォリオに新たに加わったこの製品は、グラフィックベースのビームフォーマー技術を採用しており、より高品質の画像を生成し、画像機能の柔軟性を高めています。この製品により、同社は医療機関向けの製品およびサービスプロバイダーの分野での地位をさらに強化しました。
- 2021年10月、Thynk Healthは、世界最先端の技術で肺がんと闘うためにInfervisionとの提携を発表しました。肺がんのスクリーニングと肺結節の管理の機会を提供します。この提携により、同社は市場での存在感を高めました。
ヨーロッパの肺がんスクリーニングソフトウェア市場の範囲
ヨーロッパの肺がんスクリーニング ソフトウェア市場は、配信モード、製品、タイプ、アプリケーション、プラットフォーム、購入モード、エンド ユーザー、および流通チャネルに基づいて、8 つの主要なセグメントに分割されています。これらのセグメントの成長は、業界のわずかな成長セグメントの分析に役立ち、ユーザーに貴重な市場の概要と市場の洞察を提供し、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。
配送方法
- クラウドベースのソリューション
- オンプレミスソリューション
- ウェブベースのソリューション
配信モードに基づいて、市場はクラウドベースのソリューション、オンプレミスソリューション、Web ベースのソリューションに分類されます。
製品
- 肺がんスクリーニング放射線ソリューション
- 肺がんスクリーニング患者管理ソフトウェア
- 結節管理ソフトウェア
- データ収集とレポート
- 患者の調整とワークフロー
- 肺結節のコンピュータ支援検出
- 病理学と癌のステージ分類
- 統計監査報告
- スクリーニングPACS
- 実務管理
- 監査ログの追跡
製品に基づいて、市場は、肺がんスクリーニング放射線ソリューション、肺がんスクリーニング患者管理ソフトウェア、結節管理ソフトウェア、データ収集とレポート、患者調整とワークフロー、肺結節コンピューター支援検出、病理学とがんのステージング、統計監査レポート、スクリーニングPACS、診療管理、および監査ログ追跡に分類されます。
タイプ
- コンピュータ支援スクリーニング
- 従来のスクリーニング
タイプに基づいて、市場はコンピューター支援スクリーニングと従来のスクリーニングに分類されます。
応用
- 非小細胞肺がん（NSCLC）
- 小細胞肺がん（SCLC）
用途に基づいて、市場は非小細胞肺がん (NSCLC) と小細胞肺がん (SCLC) に分類されます。
プラットフォーム
- スタンドアロン
- 統合された
プラットフォームに基づいて、市場はスタンドアロンと統合に分割されます。
購入モード
- 機関
- 個人
購入モードに基づいて、市場は個人と機関に分割されます。
エンドユーザー
- 腫瘍学センター
- 病院
- 外来手術センター
- その他
エンドユーザーに基づいて、市場は病院、腫瘍学センター、外来手術センター、その他に分類されます。
流通チャネル別
- 直接入札
- サードパーティ販売業者
流通チャネルに基づいて、市場は直接入札とサードパーティの販売業者に分割されます。
ヨーロッパの肺がんスクリーニングソフトウェア市場の地域分析/洞察
ヨーロッパの肺がんスクリーニング ソフトウェア市場が分析され、上記のように配信モード、製品、タイプ、アプリケーション、プラットフォーム、購入モード、エンド ユーザー、および流通チャネルに基づいて市場規模の洞察と傾向が提供されます。
この市場レポートで取り上げられている国は、ドイツ、イギリス、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他のヨーロッパ諸国です。肺がんはヨーロッパにおけるがんによる死亡の主な原因であり、早期診断のために肺がんスクリーニングソフトウェアを導入する必要があることから、ドイツが市場を独占しています。さらに、ヨーロッパ地域では医療施設のレベルが高度化していることも、この地域の市場の大幅な成長につながっています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、個々の国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、国内関税の影響、貿易ルートも考慮されます。
競争環境と欧州の肺がんスクリーニングソフトウェア市場シェア分析
ヨーロッパの肺がんスクリーニング ソフトウェア市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、ヨーロッパでのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。
この市場で活動している主要企業としては、PenRad Technologies Inc.、Koninklijke Philips NV、Volpara Health Limited、Thynk Health、Nuance Communications, Inc.、Siemens Healthcare GmBH、MyCareWare, Inc.、MagView、MeVis Medical Solutions AG、Canon Medical Informatics, Inc.、General Electric Company、Epic Systems Corporation、Lungview、Eon、Medtronic、Coreline Soft, Co., Ltd.、Optellum Ltd、HealthMyne、Oncocyte Corporation、Genesystem、REVEALDX、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche Ltd、Median Technologies、AstraZeneca、Aidence.com などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe lung cancer screening software market
- LIMITATION
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- market application coverage grid
- mode of delivery LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- REGULATIONS & REIMBURSEMENT
- IMPACT OF COVID-19 PANDEMIC ON THE MARKET
- Price impact
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- Market Overview
- drivers
- Increasing prevalence of lung cancer cases Europely
- Increasing awareness regarding the benefits of early diagnosis and frequent screening
- Government initiatives undertaken to implement screening programs for various diseases
- Growing number of screening programs across the globe
- Technological advancementS in THE field of healthcare
- RESTRAINTS
- issues related with the availability of software
- Scarcity of technically knowledgeable professionals for cancer diagnosis
- Lack of funding and other resources from various regions for cancer and associated disorders
- OPPORTUNITIES
- Rising collaborations, mergerS & acquisitions among the market players
- Increasing investmentS in healthcare segmentS
- Multiple benefits associated with lung cancer screening software
- CHALLENGES
- High cost of screening software and related services
- Increasing challenges related to development of lung cancer screening software
- Increasing competition in the market
- EUROPE lung cancer screening software MARKET, BY MODE OF DELIVERY
- overview
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
- overview
- Lung Cancer Screening Radiology Solution
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Cancer Screening Patient Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Nodule Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Data Collection and Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Patient Coordination and Workflow
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Nodule Computer Aided Detection
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Pathology and Cancer Staging
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Statistical Audit Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Screening PACs
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Practice Management
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Audit Log Tracking
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY type
- overview
- Computer-Assisted Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Traditional Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY application
- overview
- Non-Small Cell Lung Cancer (NSCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Small Cell Lung Cancer (SCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY platform
- overview
- Standalone
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Integrated
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Purchase Mode
- overview
- Institutional
- INDIVIDUAL
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY end user
- overview
- Oncology Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Distribution Channel
- overview
- Direct Tenders
- Third Party Distributor
- Europe lung cancer screening software Market, by Geography
- Europe
- germany
- France
- U.K
- Italy
- SPAIN
- NETHERLANDS
- RUSSIA
- Switzerland
- BELGIUM
- Philippines
- Rest of Europe
- Europe Lung cancer screening software market, COMPANY landscape
- company share analysis: Europe
- Swot analysis
- CompanY profiles
- KONINKLIJKE PHILIPS N.v
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Nuance Communications, Inc.
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Siemens Healthcare GmbH
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Lungview
- COMPANY SNAPSHot
- company share analysis
- Solution Portfolio
- RECENT DEVELOPMENT
- Medtronic
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Thynk health
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- Vital Images (A subsidiary of Canon Group Company)
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- MeVis Medical Solutions AG
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- HealthMyne
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- Volpara Solutions Limited
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Coreline Soft, Co., Ltd.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- EON
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- MyCareWare Inc
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENT
- Optellum Ltd
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- PenRad Technologies Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- ProVation Medical, Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
表のリスト
TABLE 1 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 2 Europe Cloud Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 3 Europe On-Premise Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 4 Europe Web Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 5 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 6 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 7 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 8 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 9 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 10 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 11 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 12 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 13 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 14 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 15 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 16 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 17 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 18 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 19 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 20 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 21 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 22 Europe Screening PACs in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 23 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 24 Europe Practice Management in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 25 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 26 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 27 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 28 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 29 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 30 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 31 Europe Traditional Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 32 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 33 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 34 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 35 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Product Type, 2018-2027 (USD Thousand)
TABLE 36 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 37 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 38 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 39 Europe Standalone in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 40 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 41 Europe Integrated in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 42 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 43 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 44 Europe Institutional in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 45 Europe Individual in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 46 Europe Lung Cancer Screening Software Market, By end user, 2018-2027 (USD Thousand)
TABLE 47 Europe Oncology Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 48 Europe Hospitals in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 49 Europe Ambulatory Surgical Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 50 Europe Others in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 51 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 52 Europe Direct Tenders in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 53 Europe Third Party Distributor in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 54 EUROPE LUNG CANCER SCREENING SOFTWARE market, By Country, 2018–2027 (USD thousand)
TABLE 55 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 56 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 57 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 58 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 59 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 60 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 61 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 62 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 63 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 64 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 65 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 66 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 67 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 68 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 69 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 70 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 71 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 72 Europe Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 73 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 74 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 75 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 76 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 77 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 78 Europe Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 79 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 80 Germany Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 81 Germany Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 82 Germany Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 83 Germany Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 84 Germany Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 85 Germany Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 86 Germany Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 87 Germany Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 88 Germany Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 89 Germany Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 90 Germany Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 91 Germany Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 92 Germany Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 93 Germany Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 94 Germany Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 95 Germany Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 96 Germany Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 97 Germany Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 98 Germany Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 99 Germany Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 100 Germany Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 101 Germany Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 102 Germany Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 103 Germany Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 104 Germany Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 105 France Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 106 France Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 107 France Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 108 France Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 109 France Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 110 France Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 111 France Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 112 France Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 113 France Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 114 France Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 115 France Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 116 France Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 117 France Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 118 France Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 119 France Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 120 France Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 121 France Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 122 France Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 123 France Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 124 France Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 125 France Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 126 France Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 127 France Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 128 France Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 129 France Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 130 U.K Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 131 U.K Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 132 U.K Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 133 U.K Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 134 U.K Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 135 U.K Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 136 U.K Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 137 U.K Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 138 U.K Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 139 U.K Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 140 U.K Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 141 U.K Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 142 U.K Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 143 U.K Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 144 U.K Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 145 U.K Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 146 U.K Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 147 U.K Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 148 U.K Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 149 U.K Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 150 U.K Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 151 U.K Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 152 U.K Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 153 U.K Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 154 U.K Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 155 Italy Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 156 Italy Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 157 Italy Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 158 Italy Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 159 Italy Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 160 Italy Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 161 Italy Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 162 Italy Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 163 Italy Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 164 Italy Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 165 Italy Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 166 Italy Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 167 Italy Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 168 Italy Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 169 Italy Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 170 Italy Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 171 Italy Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 172 Italy Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 173 Italy Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 174 Italy Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 175 Italy Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 176 Italy Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 177 Italy Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 178 Italy Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 179 Italy Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 180 Spain Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 181 Spain Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 182 Spain Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 183 Spain Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 184 Spain Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 185 Spain Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 186 Spain Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 187 Spain Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 188 Spain Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 189 Spain Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 190 Spain Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 191 Spain Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 192 Spain Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 193 Spain Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 194 Spain Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 195 Spain Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 196 Spain Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 197 Spain Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 198 Spain Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 199 Spain Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 200 Spain Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 201 Spain Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 202 Spain Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 203 Spain Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 204 Spain Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 205 Netherlands Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 206 Netherlands Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 207 Netherlands Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 208 Netherlands Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 209 Netherlands Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 210 Netherlands Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 211 Netherlands Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 212 Netherlands Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 213 Netherlands Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 214 Netherlands Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 215 Netherlands Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 216 Netherlands Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 217 Netherlands Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 218 Netherlands Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 219 Netherlands Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 220 Netherlands Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 221 Netherlands Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 222 Netherlands Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 223 Netherlands Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 224 Netherlands Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 225 Netherlands Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 226 Netherlands Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 227 Netherlands Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 228 Netherlands Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 229 Netherlands Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 230 Russia Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 231 Russia Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 232 Russia Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 233 Russia Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 234 Russia Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 235 Russia Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 236 Russia Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 237 Russia Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 238 Russia Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 239 Russia Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 240 Russia Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 241 Russia Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 242 Russia Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 243 Russia Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 244 Russia Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 245 Russia Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 246 Russia Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 247 Russia Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 248 Russia Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 249 Russia Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 250 Russia Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 251 Russia Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 252 Russia Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 253 Russia Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 254 Russia Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 255 Switzerland Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 256 Switzerland Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 257 Switzerland Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 258 Switzerland Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 259 Switzerland Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 260 Switzerland Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 261 Switzerland Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 262 Switzerland Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 263 Switzerland Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 264 Switzerland Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 265 Switzerland Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 266 Switzerland Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 267 Switzerland Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 268 Switzerland Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 269 Switzerland Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 270 Switzerland Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 271 Switzerland Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 272 Switzerland Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 273 Switzerland Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 274 Switzerland Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 275 Switzerland Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 276 Switzerland Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 277 Switzerland Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 278 Switzerland Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 279 Switzerland Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 280 Belgium Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 281 Belgium Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 282 Belgium Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 283 Belgium Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 284 Belgium Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 285 Belgium Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 286 Belgium Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 287 Belgium Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 288 Belgium Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 289 Belgium Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 290 Belgium Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 291 Belgium Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 292 Belgium Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 293 Belgium Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 294 Belgium Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 295 Belgium Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 296 Belgium Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 297 Belgium Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 298 Belgium Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 299 Belgium Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 300 Belgium Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 301 Belgium Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 302 Belgium Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 303 Belgium Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 304 Belgium Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 305 Turkey Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 306 Turkey Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 307 Turkey Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 308 Turkey Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 309 Turkey Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 310 Turkey Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 311 Turkey Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 312 Turkey Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 313 Turkey Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 314 Turkey Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 315 Turkey Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 316 Turkey Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 317 Turkey Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 318 Turkey Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 319 Turkey Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 320 Turkey Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 321 Turkey Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 322 Turkey Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 323 Turkey Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 324 Turkey Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 325 Turkey Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 326 Turkey Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 327 Turkey Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 328 Turkey Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 329 Turkey Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 330 REST of Asia Pacific Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
図表一覧
FIGURE 1 Europe lung cancer screening software market: segmentation
FIGURE 2 Europe lung cancer screening software market: data triangulation
FIGURE 3 Europe lung cancer screening software market: DROC ANALYSIS
FIGURE 4 Europe lung cancer screening software market: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe lung cancer screening software market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Lung cancer screening software MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 7 Europe lung cancer screening software market: INTERVIEW DEMOGRAPHICS
FIGURE 8 Europe lung cancer screening software market: DBMR MARKET POSITION GRID
FIGURE 9 Europe lung cancer screening software market: vendor share analysis
FIGURE 10 Europe lung cancer screening software market: SEGMENTATION
FIGURE 11 RISING lung cancer screening programs and Technological advancement in THE field of healthcare is expected to drive THE Europe lung cancer screening software market IN THE FORECAST PERIOD of 2020 to 2027
FIGURE 12 Cloud based solutions segment is expected to account for the largest share of Europe lung cancer screening software market in 2020 & 2027
FIGURE 13 Drivers, RestrainTs, OPPORTUNITIES & challenges OF Europe Lung Cancer Screening Software market
FIGURE 14 Lung Cancer incidence and mortality rates, 2018
FIGURE 15 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY mode of delivery, 2019
FIGURE 16 Europe Lung cancer screening software market: BY Mode of Delivery, 2019-2027 (USD Thousand)
FIGURE 17 Europe Lung cancer screening software market: BY Mode of Delivery, CAGR (2020-2027)
FIGURE 18 Europe Lung cancer screening software market: BY Mode of Delivery, LIFELINE CURVE
FIGURE 19 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY product, 2019
FIGURE 20 Europe Lung cancer screening software market: BY product, 2019-2027 (USD Thousand)
FIGURE 21 Europe Lung cancer screening software market: BY product, CAGR (2020-2027)
FIGURE 22 Europe Lung cancer screening software market: BY product, LIFELINE CURVE
FIGURE 23 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY type, 2019
FIGURE 24 Europe Lung cancer screening software market: BY type, 2019-2027 (USD Thousand)
FIGURE 25 Europe Lung cancer screening software market: BY type, CAGR (2020-2027)
FIGURE 26 Europe Lung cancer screening software market: BY type, LIFELINE CURVE
FIGURE 27 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY application, 2019
FIGURE 28 Europe Lung cancer screening software market: BY application, 2019-2027 (USD Thousand)
FIGURE 29 Europe Lung cancer screening software market: BY application, CAGR (2020-2027)
FIGURE 30 Europe Lung cancer screening software market: BY application, LIFELINE CURVE
FIGURE 31 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY platform, 2019
FIGURE 32 Europe Lung cancer screening software market: BY platform, 2019-2027 (USD Thousand)
FIGURE 33 Europe Lung cancer screening software market: BY platform, CAGR (2020-2027)
FIGURE 34 Europe Lung cancer screening software market: BY platform, LIFELINE CURVE
FIGURE 35 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Purchase Mode, 2019
FIGURE 36 Europe Lung cancer screening software market: BY Purchase Mode, 2019-2027 (USD Thousand)
FIGURE 37 Europe Lung cancer screening software market: BY Purchase Mode, CAGR (2020-2027)
FIGURE 38 Europe Lung cancer screening software market: BY Purchase Mode, LIFELINE CURVE
FIGURE 39 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY end user, 2019
FIGURE 40 Europe Lung cancer screening software market: BY end user, 2019-2027 (USD Thousand)
FIGURE 41 Europe Lung cancer screening software market: BY end user, CAGR (2020-2027)
FIGURE 42 Europe Lung cancer screening software market: BY end user, LIFELINE CURVE
FIGURE 43 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Distribution Channel, 2019
FIGURE 44 Europe Lung cancer screening software market: BY distribution channel, 2019-2027 (USD Thousand)
FIGURE 45 Europe Lung cancer screening software market: BY distribution channel, CAGR (2020-2027)
FIGURE 46 Europe Lung cancer screening software market: BY distribution channel, LIFELINE CURVE
FIGURE 47 EUROPE Lung cancer screening software MARKET: SNAPSHOT (2019)
FIGURE 48 EUROPE Lung cancer screening software MARKET: by COUNTRY (2020)
FIGURE 49 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 50 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 51 EUROPE Lung cancer screening software MARKET: by TYPE (2020-2027)
FIGURE 52 Europe Lung cancer screening software market: company share 2019 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
